Logo image of JHX

JAMES HARDIE IND PLC (JHX) Stock Fundamental Analysis

NYSE:JHX - New York Stock Exchange, Inc. - US47030M1062 - Common Stock - Currency: USD

28.77  +0.42 (+1.48%)

After market: 28.77 0 (0%)

Fundamental Rating

6

Overall JHX gets a fundamental rating of 6 out of 10. We evaluated JHX against 12 industry peers in the Construction Materials industry. JHX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. JHX has a correct valuation and a medium growth rate. This makes JHX very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

JHX had positive earnings in the past year.
In the past year JHX had a positive cash flow from operations.
Each year in the past 5 years JHX has been profitable.
Each year in the past 5 years JHX had a positive operating cash flow.
JHX Yearly Net Income VS EBIT VS OCF VS FCFJHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

JHX's Return On Assets of 8.11% is in line compared to the rest of the industry. JHX outperforms 58.33% of its industry peers.
Looking at the Return On Equity, with a value of 19.62%, JHX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
JHX has a Return On Invested Capital of 12.97%. This is amongst the best in the industry. JHX outperforms 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JHX is above the industry average of 10.74%.
Industry RankSector Rank
ROA 8.11%
ROE 19.62%
ROIC 12.97%
ROA(3y)9.97%
ROA(5y)9.43%
ROE(3y)26.28%
ROE(5y)27.61%
ROIC(3y)13.97%
ROIC(5y)14.14%
JHX Yearly ROA, ROE, ROICJHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

JHX's Profit Margin of 10.93% is in line compared to the rest of the industry. JHX outperforms 58.33% of its industry peers.
JHX's Profit Margin has improved in the last couple of years.
JHX has a better Operating Margin (22.19%) than 75.00% of its industry peers.
In the last couple of years the Operating Margin of JHX has grown nicely.
Looking at the Gross Margin, with a value of 38.81%, JHX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
JHX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.19%
PM (TTM) 10.93%
GM 38.81%
OM growth 3Y-0.52%
OM growth 5Y3.46%
PM growth 3Y-4.87%
PM growth 5Y3.37%
GM growth 3Y2.21%
GM growth 5Y1.56%
JHX Yearly Profit, Operating, Gross MarginsJHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), JHX is creating value.
The number of shares outstanding for JHX has been reduced compared to 1 year ago.
JHX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for JHX has been reduced compared to a year ago.
JHX Yearly Shares OutstandingJHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
JHX Yearly Total Debt VS Total AssetsJHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 4.37 indicates that JHX is not in any danger for bankruptcy at the moment.
JHX has a Altman-Z score of 4.37. This is in the better half of the industry: JHX outperforms 75.00% of its industry peers.
JHX has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as JHX would need 2.95 years to pay back of all of its debts.
JHX has a better Debt to FCF ratio (2.95) than 91.67% of its industry peers.
A Debt/Equity ratio of 0.51 indicates that JHX is somewhat dependend on debt financing.
The Debt to Equity ratio of JHX (0.51) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.95
Altman-Z 4.37
ROIC/WACC1.8
WACC7.2%
JHX Yearly LT Debt VS Equity VS FCFJHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

JHX has a Current Ratio of 2.10. This indicates that JHX is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.10, JHX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
JHX has a Quick Ratio of 1.67. This is a normal value and indicates that JHX is financially healthy and should not expect problems in meeting its short term obligations.
JHX has a Quick ratio of 1.67. This is amongst the best in the industry. JHX outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.67
JHX Yearly Current Assets VS Current LiabilitesJHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

5

3. Growth

3.1 Past

The earnings per share for JHX have decreased by -7.45% in the last year.
JHX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.73% yearly.
The Revenue has decreased by -1.49% in the past year.
JHX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)-7.45%
EPS 3Y2.07%
EPS 5Y13.73%
EPS Q2Q%-10%
Revenue 1Y (TTM)-1.49%
Revenue growth 3Y2.37%
Revenue growth 5Y8.27%
Sales Q2Q%-3.32%

3.2 Future

JHX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.48% yearly.
JHX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.32% yearly.
EPS Next Y6.13%
EPS Next 2Y11.95%
EPS Next 3Y10.76%
EPS Next 5Y15.48%
Revenue Next Year10.68%
Revenue Next 2Y12.16%
Revenue Next 3Y11.95%
Revenue Next 5Y15.32%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JHX Yearly Revenue VS EstimatesJHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
JHX Yearly EPS VS EstimatesJHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.31, JHX is valued on the expensive side.
Based on the Price/Earnings ratio, JHX is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of JHX to the average of the S&P500 Index (27.45), we can say JHX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.16, JHX is valued on the expensive side.
JHX's Price/Forward Earnings is on the same level as the industry average.
JHX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.31
Fwd PE 18.16
JHX Price Earnings VS Forward Price EarningsJHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JHX is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JHX indicates a somewhat cheap valuation: JHX is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 32.49
EV/EBITDA 12.01
JHX Per share dataJHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
JHX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.15
PEG (5Y)1.41
EPS Next 2Y11.95%
EPS Next 3Y10.76%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.07%, JHX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.22, JHX pays a better dividend. On top of this JHX pays more dividend than 91.67% of the companies listed in the same industry.
JHX's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.07%

5.2 History

JHX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
JHX Yearly Dividends per shareJHX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2Y11.95%
EPS Next 3Y10.76%
JHX Yearly Income VS Free CF VS DividendJHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

JAMES HARDIE IND PLC

NYSE:JHX (7/3/2025, 7:42:07 PM)

After market: 28.77 0 (0%)

28.77

+0.42 (+1.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-10 2025-08-10/bmo
Inst Owners55.56%
Inst Owner Change318.32%
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap12.37B
Analysts73.75
Price Target29.18 (1.43%)
Short Float %9.17%
Short Ratio8.6
Dividend
Industry RankSector Rank
Dividend Yield 2.07%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.12%
Min EPS beat(2)-2.01%
Max EPS beat(2)2.25%
EPS beat(4)3
Avg EPS beat(4)2.57%
Min EPS beat(4)-2.01%
Max EPS beat(4)6.34%
EPS beat(8)5
Avg EPS beat(8)2.59%
EPS beat(12)6
Avg EPS beat(12)-0.6%
EPS beat(16)7
Avg EPS beat(16)-1.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)-1.51%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)-1.51%
Revenue beat(8)3
Avg Revenue beat(8)-0.54%
Revenue beat(12)5
Avg Revenue beat(12)-1.34%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)-9.25%
PT rev (3m)-19.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.87%
Valuation
Industry RankSector Rank
PE 19.31
Fwd PE 18.16
P/S 3.19
P/FCF 32.49
P/OCF 15.4
P/B 5.72
P/tB 6.79
EV/EBITDA 12.01
EPS(TTM)1.49
EY5.18%
EPS(NY)1.58
Fwd EY5.51%
FCF(TTM)0.89
FCFY3.08%
OCF(TTM)1.87
OCFY6.49%
SpS9.02
BVpS5.03
TBVpS4.24
PEG (NY)3.15
PEG (5Y)1.41
Profitability
Industry RankSector Rank
ROA 8.11%
ROE 19.62%
ROCE 19.47%
ROIC 12.97%
ROICexc 14.87%
ROICexgc 16.3%
OM 22.19%
PM (TTM) 10.93%
GM 38.81%
FCFM 9.82%
ROA(3y)9.97%
ROA(5y)9.43%
ROE(3y)26.28%
ROE(5y)27.61%
ROIC(3y)13.97%
ROIC(5y)14.14%
ROICexc(3y)15.23%
ROICexc(5y)15.2%
ROICexgc(3y)16.77%
ROICexgc(5y)16.93%
ROCE(3y)20.96%
ROCE(5y)21.22%
ROICexcg growth 3Y-3.58%
ROICexcg growth 5Y8.58%
ROICexc growth 3Y-2.86%
ROICexc growth 5Y9.05%
OM growth 3Y-0.52%
OM growth 5Y3.46%
PM growth 3Y-4.87%
PM growth 5Y3.37%
GM growth 3Y2.21%
GM growth 5Y1.56%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.95
Debt/EBITDA 1.03
Cap/Depr 195.28%
Cap/Sales 10.89%
Interest Coverage 13.53
Cash Conversion 74.58%
Profit Quality 89.76%
Current Ratio 2.1
Quick Ratio 1.67
Altman-Z 4.37
F-Score6
WACC7.2%
ROIC/WACC1.8
Cap/Depr(3y)260.24%
Cap/Depr(5y)204.41%
Cap/Sales(3y)12.65%
Cap/Sales(5y)9.78%
Profit Quality(3y)61.36%
Profit Quality(5y)110.03%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.45%
EPS 3Y2.07%
EPS 5Y13.73%
EPS Q2Q%-10%
EPS Next Y6.13%
EPS Next 2Y11.95%
EPS Next 3Y10.76%
EPS Next 5Y15.48%
Revenue 1Y (TTM)-1.49%
Revenue growth 3Y2.37%
Revenue growth 5Y8.27%
Sales Q2Q%-3.32%
Revenue Next Year10.68%
Revenue Next 2Y12.16%
Revenue Next 3Y11.95%
Revenue Next 5Y15.32%
EBIT growth 1Y-8.4%
EBIT growth 3Y1.83%
EBIT growth 5Y12.01%
EBIT Next Year36.44%
EBIT Next 3Y23.39%
EBIT Next 5Y24.62%
FCF growth 1Y-18.13%
FCF growth 3Y-8.66%
FCF growth 5Y8.14%
OCF growth 1Y-12.19%
OCF growth 3Y1.97%
OCF growth 5Y12.21%